North America Enteral Medical Nutrition Market Forecast to 2028 - COVID-19 Impact and Regional Analysis - by Indication, Nutrition Type, Form, Product, Distribution Channel, and Age Group

Description

List of Tables

The enteral medical nutrition market in North America is expected to grow from US$ 3,602.61 million in 2022 to US$ 5,043.51 million by 2028. It is estimated to grow at a CAGR of 5.8% from 2022 to 2028.

Increase in Prevalence of Cachexia

Cachexia is a multifunctional disease that causes extreme weight loss, skeletal muscle and adipose tissue loss, metabolic regulation imbalance, and food intake reduction. It is a serious clinical consequence of almost all chronic diseases when reaching advanced stages. In 2016, cachexia prevalence ranged from 5 to 15% in end-stage chronic heart failure. It is frequently occurring in patients suffering from chronic kidney disease, chronic obstructive pulmonary disease (COPD), neurological disease, and rheumatoid arthritis. Mortality rates of cachexia patients range from 15 to 25% per year in patients with severe COPD and from 20 to 40% per year in patients with chronic heart failure or chronic kidney disease.

Cancer cachexia negatively affects the quality of life of cancer patients and reduces the effectiveness of anticancer chemotherapy and increases its toxicity, leading to growth in cancer-related mortality and medical resources expenditure. In cachexia the nutrient in the body decreases therefore it is necessary to provide external nutrients to continue the treatment for cancer and COPD. Doctors prefer enteral route to provide these required nutrients to the patient. Therefore, growing prevalence of cachexia due to the rising incidence of various chronic diseases fuels the growth of the enteral medical nutrition market.

Market Overview

The North America enteral medical nutrition market has been segmented into the US, Canada, and Mexico. The US held the largest share of the North America enteral medical nutrition market in 2021. The increasing prevalence of chronic diseases followed by rising research and development activities by various major firms, increasing expenditure on patient care, and increasing preference for enteral nutrition ultimately drive the overall enteral medical nutrition market during the forecast period. Further, The US enteral medical nutrition market holds the largest share in the North America region. The rising prevalence of chronic diseases is likely to favor market growth. Chronic diseases such as cancer, heart disease, and diabetes are the leading causes of disability and death in the US. As per the National Center for Chronic Disease Prevention and Health Promotion, six in ten Americans have at least one chronic disease, such as heart disease, stroke, cancer, diabetes, and others.

Increasing expenditure on chronic health conditions is likely to favor market growth. In 2016, the total costs in the US. for direct treatment for chronic diseases was US$1.1 trillion, equivalent to around 6% of the nation's GDP. Further, in 2020, the total expenditure of chronic diseases in the US reached US$3.7 trillion, which is around 19.6% of the country's GDP.

The US government is taking many initiatives to boost the enteral nutrition market. For instance, the Feeding Tube Awareness Foundation is creating awareness about feeding tube adoption. The foundation has celebrated the annual Feeding Tube Awareness Week from February 4 to February 8, 2019. More than 500,000 children and adults in the US depend on enteral feeding for nutrition, and the number is expected to increase in the forecast period.

North America Enteral Medical Nutrition Market Revenue and Forecast to 2028 (US$ Million)

North America Enteral Medical Nutrition Market Segmentation

The North America enteral medical nutrition market is segmented into indication, nutrition type, form, product, distribution channel, age group and country.

Based on indication, the North America enteral medical nutrition market is segmented into respiratory disorders, cancer, post COVID-19, gastrointestinal disorders, liver failure, and others. The respiratory disorders segment held the largest share in 2022. Based on nutrition type, the North America enteral medical nutrition market is segmented into supplemental and sole source. The supplemental segment held the largest share of the market in 2022. Based on form, the North America enteral medical nutrition market is segmented into powder, liquid, and semi-solid. The semi-solid segment held the largest share of the market in 2022. Based on product, the North America enteral medical nutrition market is segmented into standard protein diet, high protein diet, fruit juice based oral nutrition, and others. The standard protein diet segment held the largest share of the market in 2022. Based on distribution channel, the North America Enteral Medical Nutrition market is segmented into Hospital Pharmacies, Retail Stores and Other Pharmacies. The Hospital pharmacies segment held the largest share of the market in 2022. Based on Age Group, the North America enteral medical nutrition market is segmented into child (till 18 years) and adults (above 18 years). The adult segment held the largest share of the market in 2022. Based on country, the market is segmented into the US, Canada, and Mexico. The US dominated the market in 2022. Abbott Laboratories; B. Braun Melsungen AG; DSM Nutritional Products AG; Fresenius Kabi AG; Global Health Products, Inc.; Hormel Foods Corporation; Meiji Holdings Co., Ltd.; Nestle S.A.; Nutricia; and Smartfish AS are the leading companies operating in the enteral medical nutrition market in the region.

Reasons to Buy:

Save and reduce time carrying out entry-level research by identifying the growth, size, leading players and segments in the North America enteral medical nutrition market
Highlights key business priorities in order to assist companies to realign their business strategies
The key findings and recommendations highlight crucial progressive industry trends in the North America enteral medical nutrition market, thereby allowing players across the value chain to develop effective long-term strategies
Develop/modify business expansion plans by using substantial growth offering developed and emerging markets
Scrutinize in-depth North America market trends and outlook coupled with the factors driving the enteral medical nutrition market, as well as those hindering it
Enhance the decision-making process by understanding the strategies that underpin commercial interest with respect to client products, segmentation, pricing and distribution

Product Code: BMIRE00027523

1. Introduction

1.1 Scope of the Study
1.2 The Insight Partners Research Report Guidance
1.3 Market Segmentation
- 1.3.1 North America Enteral Medical Nutrition Market - By Indication
- 1.3.2 North America Enteral Medical Nutrition Market - By Nutrition Type
- 1.3.3 North America Enteral Medical Nutrition Market - By Form
- 1.3.4 North America Enteral Medical Nutrition Market - By Product
- 1.3.5 North America Enteral Medical Nutrition Market - By Distribution Channel
- 1.3.6 North America Enteral Medical Nutrition Market - By Age Group
- 1.3.7 North America Enteral Medical Nutrition Market - By Country

2. Key Takeaways

3. Research Methodology

3.1 Coverage
3.2 Secondary Research
3.3 Primary Research

4. North America Enteral Medical Nutrition Market - Market Landscape

4.1 Overview
4.2 North America PEST Analysis
- 4.2.1 North America PEST Analysis
4.3 Experts Opinion

5. North America Enteral Medical Nutrition Market - Key Market Dynamics

5.1 Market Drivers
- 5.1.1 Increase in Prevalence of Cachexia
- 5.1.2 Rise in Prevalence of Gastrointestinal Diseases
5.2 Market Restraints
- 5.2.1 Complications of Enteral Nutrition
5.3 Market Opportunities
- 5.3.1 Use of Next Generation Technology for Proper Enteral Nutrition Feeding
5.4 Future Trends
- 5.4.1 Developments Related to Enteral Medical Nutrition Products
5.5 Impact Analysis

6. Enteral Medical Nutrition Market - North America Analysis

6.1 North America Enteral Medical Nutrition Market Revenue Forecast and Analysis

7. Enteral Medical Nutrition Market Analysis and Forecast to 2028 - Indication

7.1 Overview
7.2 North America Enteral Medical Nutrition Market, by Indication, 2022 & 2028 (%)
7.3 Respiratory Disorders
- 7.3.1 Overview
- 7.3.2 Respiratory Disorders Market Revenue and Forecast to 2028 (US$ Million)
- 7.3.3 Chronic Obstructive Pulmonary Disease
  - 7.3.3.1 Overview
  - 7.3.3.2 Chronic Obstructive Pulmonary Disease Market Revenue and Forecast to 2028 (US$ Million)
- 7.3.4 Respiratory Failure
  - 7.3.4.1 Overview
  - 7.3.4.2 Respiratory Failure Market Revenue and Forecast to 2028 (US$ Million)
- 7.3.5 Cystic Fibrosis
  - 7.3.5.1 Overview
  - 7.3.5.2 Cystic Fibrosis Market Revenue and Forecast to 2028 (US$ Million)
- 7.3.6 Others
  - 7.3.6.1 Overview
  - 7.3.6.2 Others Market Revenue and Forecast to 2028 (US$ Million)
7.4 Cancer
- 7.4.1 Overview
- 7.4.2 Cancer Market Revenue and Forecast to 2028 (US$ Million)
- 7.4.3 Cancer Cachexia
  - 7.4.3.1 Overview
  - 7.4.3.2 Cancer Cachexia Market Revenue and Forecast to 2028 (US$ Million)
- 7.4.4 Cachexia with COPD
  - 7.4.4.1 Overview
  - 7.4.4.2 Cachexia with COPD Market Revenue and Forecast to 2028 (US$ Million)
- 7.4.5 Others
  - 7.4.5.1 Overview
  - 7.4.5.2 Others Market Revenue and Forecast to 2028 (US$ Million)
7.5 Post COVID-19
- 7.5.1 Overview
- 7.5.2 Post COVID-19 Market Revenue and Forecast to 2028 (US$ Million)
7.6 Gastrointestinal Disorders
- 7.6.1 Overview
- 7.6.2 Gastrointestinal Disorders Market Revenue and Forecast to 2028 (US$ Million)
- 7.6.3 Bowel Obstruction
  - 7.6.3.1 Overview
  - 7.6.3.2 Bowel Obstruction Market Revenue and Forecast to 2028 (US$ Million)
- 7.6.4 Crohn's Disease
  - 7.6.4.1 Overview
  - 7.6.4.2 Crohn's Disease Market Revenue and Forecast to 2028 (US$ Million)
- 7.6.5 Short Bowel Syndrome
  - 7.6.5.1 Overview
  - 7.6.5.2 Short Bowel Syndrome Market Revenue and Forecast to 2028 (US$ Million)
- 7.6.6 Others
  - 7.6.6.1 Overview
  - 7.6.6.2 Others Market Revenue and Forecast to 2028 (US$ Million)
7.7 Liver Failure
- 7.7.1 Overview
- 7.7.2 Liver Failure Market Revenue and Forecast to 2028 (US$ Million)
7.8 Others
- 7.8.1 Overview
- 7.8.2 Other Market Revenue and Forecast to 2028 (US$ Million)

8. North America Enteral Medical Nutrition Market Analysis and Forecast to 2028 - Nutrition Type

8.1 Overview
8.2 North America Enteral Medical Nutrition Market, by Nutrition Type, 2022 & 2028 (%)
8.3 Supplemental
- 8.3.1 Overview
- 8.3.2 Supplemental Market Revenue and Forecast to 2028 (US$ Million)
8.4 Sole-Source
- 8.4.1 Overview
- 8.4.2 Sole-Source Market Revenue and Forecast to 2028 (US$ Million)

9. North America Enteral Medical Nutrition Market Analysis and Forecast to 2028 - Form

9.1 Overview
9.2 North America Enteral Medical Nutrition Market, by Form, 2022 & 2028 (%)
9.3 Powder
- 9.3.1 Overview
- 9.3.2 Powder Market Revenue and Forecast to 2028 (US$ Million)
9.4 Liquid
- 9.4.1 Overview
- 9.4.2 Liquid Market Revenue and Forecast to 2028 (US$ Million)
9.5 Semi-Solid
- 9.5.1 Overview
- 9.5.2 Semi-Solid Market Revenue and Forecast to 2028 (US$ Million)

10. North America Enteral Medical Nutrition Market Analysis and Forecast to 2028 - Product

10.1 Overview
10.2 North America Enteral Medical Nutrition Market, by Product, 2022 & 2028 (%)
10.3 Standard Protein Diet
- 10.3.1 Overview
- 10.3.2 Standard Protein Diet Market Revenue and Forecast to 2028 (US$ Million)
10.4 High Protein Diet
- 10.4.1 Overview
- 10.4.2 High Protein Diet Market Revenue and Forecast to 2028 (US$ Million)
10.5 Fruit Juice Based Oral Nutritional Supplement
- 10.5.1 Overview
- 10.5.2 Fruit Juice Based Oral Nutritional Supplement Market Revenue and Forecast to 2028 (US$ Million)
10.6 Others
- 10.6.1 Overview
- 10.6.2 Other Market Revenue and Forecast to 2028 (US$ Million)

11. North America Enteral Medical Nutrition Market Analysis and Forecast to 2028 - Distribution Channel

11.1 Overview
11.2 North America Enteral Medical Nutrition Market, by Distribution Channel, 2022 & 2028 (%)
11.3 Hospital Pharmacies
- 11.3.1 Overview
- 11.3.2 Hospital Pharmacies Market Revenue and Forecast to 2028 (US$ Million)
11.4 Retail Pharmacies
- 11.4.1 Overview
- 11.4.2 Retail Pharmacies Market Revenue and Forecast to 2028 (US$ Million)
11.5 Others
- 11.5.1 Overview
- 11.5.2 Others Market Revenue and Forecast to 2028 (US$ Million)

12. North America Enteral Medical Nutrition Market Analysis and Forecast to 2028 - Age Group

12.1 Overview
12.2 North America Enteral Medical Nutrition Market, by Age Group, 2022 & 2028 (%)
12.3 Child (Till 18 Years)
- 12.3.1 Overview
- 12.3.2 Child Market Revenue and Forecast to 2028 (US$ Million)
12.4 Adult (Above 18+ Years)
- 12.4.1 Overview
- 12.4.2 Adult Market Revenue and Forecast to 2028 (US$ Million)

13. North America Enteral Medical Nutrition Market Revenue and Forecasts to 2028 - Country Analysis

13.1 Overview
- 13.1.1 North America: Enteral Medical Nutrition Market, by Country, 2021 & 2028 (%)
  - 13.1.1.1 US: Enteral Medical Nutrition Market - Revenue and Forecast to 2028 (US$ Million)
    - 13.1.1.1.1 Overview
    - 13.1.1.1.2 US: Enteral Medical Nutrition Market - Revenue and Forecast to 2028 (US$ Million)
    - 13.1.1.1.3 US: Enteral Medical Nutrition Market, by Indication, 2019-2028 (US$ Million)
    - 13.1.1.1.3.1 US: Enteral Medical Nutrition Market, by Respiratory Disorders, 2019-2028 (US$ Million)
    - 13.1.1.1.3.2 US: Enteral Medical Nutrition Market, by Cancer, 2019-2028 (US$ Million)
    - 13.1.1.1.3.3 US: Enteral Medical Nutrition Market, by Gastrointestinal Disorders, 2019-2028 (US$ Million)
    - 13.1.1.1.4 US: Enteral Medical Nutrition Market, by Nutrition Type, 2019-2028 (US$ Million)
    - 13.1.1.1.5 US: Enteral Medical Nutrition Market, by Form, 2019-2028 (US$ Million)
    - 13.1.1.1.6 US: Enteral Medical Nutrition Market, by Product, 2019-2028 (US$ Million)
    - 13.1.1.1.7 US: Enteral Medical Nutrition Market, by Distribution Channel, 2019-2028 (US$ Million)
    - 13.1.1.1.8 US: Enteral Medical Nutrition Market, by Age Group, 2019-2028 (US$ Million)
  - 13.1.1.2 Canada: Enteral Medical Nutrition Market - Revenue and Forecast to 2028 (US$ Million)
    - 13.1.1.2.1 Overview
    - 13.1.1.2.2 Canada: Enteral Medical Nutrition Market - Revenue and Forecast to 2028 (US$ Million)
    - 13.1.1.2.3 Canada: Enteral Medical Nutrition Market, by Indication, 2019-2028 (US$ Million)
    - 13.1.1.2.3.1 Canada: Enteral Medical Nutrition Market, by Respiratory Disorders, 2019-2028 (US$ Million)
    - 13.1.1.2.3.2 Canada: Enteral Medical Nutrition Market, by Cancer, 2019-2028 (US$ Million)
    - 13.1.1.2.3.3 Canada: Enteral Medical Nutrition Market, by Gastrointestinal Disorders, 2019-2028 (US$ Million)
    - 13.1.1.2.4 Canada: Enteral Medical Nutrition Market, by Nutrition Type, 2019-2028 (US$ Million)
    - 13.1.1.2.5 Canada: Enteral Medical Nutrition Market, by Form, 2019-2028 (US$ Million)
    - 13.1.1.2.6 Canada: Enteral Medical Nutrition Market, by Product, 2019-2028 (US$ Million)
    - 13.1.1.2.7 Canada: Enteral Medical Nutrition Market, by Distribution Channel, 2019-2028 (US$ Million)
    - 13.1.1.2.8 Canada: Enteral Medical Nutrition Market, by Age Group, 2019-2028 (US$ Million)
  - 13.1.1.3 Mexico: Enteral Medical Nutrition Market - Revenue and Forecast to 2028 (US$ Million)
    - 13.1.1.3.1 Overview
    - 13.1.1.3.2 Mexico: Enteral Medical Nutrition Market - Revenue and Forecast to 2028 (US$ Million)
    - 13.1.1.3.3 Mexico: Enteral Medical Nutrition Market, by Indication, 2019-2028 (US$ Million)
    - 13.1.1.3.3.1 Mexico: Enteral Medical Nutrition Market, by Respiratory Disorders, 2019-2028 (US$ Million)
    - 13.1.1.3.3.2 Mexico: Enteral Medical Nutrition Market, by Cancer, 2019-2028 (US$ Million)
    - 13.1.1.3.3.3 Mexico: Enteral Medical Nutrition Market, by Gastrointestinal Disorders, 2019-2028 (US$ Million)
    - 13.1.1.3.4 Mexico: Enteral Medical Nutrition Market, by Nutrition Type, 2019-2028 (US$ Million)
    - 13.1.1.3.5 Mexico: Enteral Medical Nutrition Market, by Form, 2019-2028 (US$ Million)
    - 13.1.1.3.6 Mexico: Enteral Medical Nutrition Market, by Product, 2019-2028 (US$ Million)
    - 13.1.1.3.7 Mexico: Enteral Medical Nutrition Market, by Distribution Channel, 2019-2028 (US$ Million)
    - 13.1.1.3.8 Mexico: Enteral Medical Nutrition Market, by Age Group, 2019-2028 (US$ Million)

14. Enteral Medical Nutrition Market- Industry Landscape

14.1 Overview
14.2 Growth Strategies Done by the Companies in the Market, (%)
14.3 Organic Developments
- 14.3.1 Overview
14.4 Inorganic Developments
- 14.4.1 Overview

15. Company Profiles

15.1 Abbott Laboratories
- 15.1.1 Key Facts
- 15.1.2 Business Description
- 15.1.3 Products and Services
- 15.1.4 Financial Overview
- 15.1.5 SWOT Analysis
- 15.1.6 Key Developments
15.2 Nutricia
- 15.2.1 Key Facts
- 15.2.2 Business Description
- 15.2.3 Products and Services
- 15.2.4 Financial Overview
- 15.2.5 SWOT Analysis
- 15.2.6 Key Developments
15.3 Fresenius Kabi AG
- 15.3.1 Key Facts
- 15.3.2 Business Description
- 15.3.3 Products and Services
- 15.3.4 Financial Overview
- 15.3.5 SWOT Analysis
- 15.3.6 Key Developments
15.4 B. Braun Melsungen AG
- 15.4.1 Key Facts
- 15.4.2 Business Description
- 15.4.3 Products and Services
- 15.4.4 Financial Overview
- 15.4.5 SWOT Analysis
- 15.4.6 Key Developments
15.5 Nestle S.A.
- 15.5.1 Key Facts
- 15.5.2 Business Description
- 15.5.3 Products and Services
- 15.5.4 Financial Overview
- 15.5.5 SWOT Analysis
- 15.5.6 Key Developments
15.6 Meiji Holdings Co., Ltd.
- 15.6.1 Key Facts
- 15.6.2 Business Description
- 15.6.3 Products and Services
- 15.6.4 Financial Overview
- 15.6.5 SWOT Analysis
- 15.6.6 Key Developments
15.7 Smartfish AS
- 15.7.1 Key Facts
- 15.7.2 Business Description
- 15.7.3 Products and Services
- 15.7.4 Financial Overview
- 15.7.5 SWOT Analysis
- 15.7.6 Key Developments
15.8 DSM Nutritional Products AG
- 15.8.1 Key Facts
- 15.8.2 Business Description
- 15.8.3 Products and Services
- 15.8.4 Financial Overview
- 15.8.5 SWOT Analysis
- 15.8.6 Key Developments
15.9 Hormel Foods Corporation
- 15.9.1 Key Facts
- 15.9.2 Business Description
- 15.9.3 Products and Services
- 15.9.4 Financial Overview
- 15.9.5 SWOT Analysis
- 15.9.6 Key Developments
15.10 Global Health Products, Inc.
- 15.10.1 Key Facts
- 15.10.2 Business Description
- 15.10.3 Products and Services
- 15.10.4 Financial Overview
- 15.10.5 SWOT Analysis
- 15.10.6 Key Developments

16. Appendix

16.1 About The Insight Partners
16.2 Glossary of Terms in Enteral Medical Nutrition Market